Epidemiology of invasive meningococcal disease in France in 2003

A Perrocheau1, M K Taha2, D Lévy-Bruhl1

  • 1Unité des maladies à prévention vaccinale, Département des maladies infectieuses, Institut de Veille Sanitaire, Saint Maurice, France.

Insights

National surveillance of invasive meningococcal disease (IMD) improved with enhanced reporting and analysis. Estimated incidence was 1.78/100,000, with highest rates in infants and young children, and serogroup B being most common.

Area of Science:

  • Epidemiology
  • Infectious Disease Surveillance
  • Public Health

Background:

  • National surveillance of invasive meningococcal disease (IMD) relies on mandatory reporting.
  • Changes in case definitions and enhanced alert systems were implemented in 2002-2003.
  • Capture-recapture analysis was used to evaluate surveillance completeness.

Purpose of the Study:

  • To assess the incidence and epidemiology of invasive meningococcal disease (IMD) in the national surveillance system.
  • To evaluate the impact of enhanced surveillance methods and case definition changes.
  • To identify high-risk age groups and serogroups for IMD.

Main Methods:

  • Utilized mandatory reporting data for invasive meningococcal disease (IMD).
  • Implemented enhanced daily reporting and weekly analysis by district, serogroup, and age.
  • Employed capture-recapture analysis to correct for underreporting.
  • Analyzed case fatality rates and serogroup distribution.

Main Results:

  • An estimated incidence of 1.78 per 100,000 was determined after correcting for underreporting.
  • Incidence was highest in infants under 1 year (20/100,000) and young children (11/100,000).
  • Serogroup B accounted for 59% of cases, followed by serogroup C (32%).
  • Case fatality rate was 12%, with lower rates in patients treated pre-hospitalization.

Conclusions:

  • Enhanced surveillance systems provide more accurate estimates of invasive meningococcal disease (IMD) burden.
  • Targeted interventions are crucial for high-incidence age groups and specific serogroups.
  • Prompt antibiotic treatment for purpura fulminans is associated with improved survival outcomes.